Winslow Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Winslow Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-33	Closed	-$2K	–	72
2018 Q4	$2K	Sell	33 -6,102,392	-100%	-$328M	﹤0.01%	88
2018 Q3	$379M	Buy	+6,102,425	New	+$362M	1.88%	16
2017 Q2	–	Sell	-1	Closed	–	–	94
2017 Q1	$0	Sell	1 -8	-89%	-$439	﹤0.01%	90
2016 Q4	$1K	Sell	9 -3,128,606	-100%	-$171M	﹤0.01%	89
2016 Q3	$169M	Sell	3,128,615 -3,820,762	-55%	-$245M	0.7%	64
2016 Q2	$511M	Sell	6,949,377 -755,259	-10%	-$53.4M	2.09%	13
2016 Q1	$492M	Sell	7,704,636 -2,241,584	-23%	-$141M	1.93%	15
2015 Q4	$684M	Buy	9,946,220 +716,356	+8%	+$47.3M	2.45%	11
2015 Q3	$546M	Buy	+9,229,864	New	+$586M	1.99%	13
2015 Q1	–	Sell	-13	Closed	-$1K	–	68
2014 Q4	$1K	Hold	13	–	–	﹤0.01%	72
2014 Q3	$1K	Hold	13	–	–	﹤0.01%	67
2014 Q2	$1K	Sell	13 -103	-89%	-$5.08K	﹤0.01%	73
2014 Q1	$6K	Sell	116 -5,581,879	-100%	-$297M	﹤0.01%	72
2013 Q4	$297M	Buy	+5,581,995	New	+$284M	0.87%	52

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Winslow Capital Management's BMY Position: Q1 2019 in Review

Winslow Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 33 shares — an estimated $2K sold.

Winslow Capital Management first reported a position in BMY in Q4 2013 and held it in 14 quarters. The position peaked at $684M in Q4 2015. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Winslow Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
Winslow Capital Management sold 33 Bristol-Myers Squibb shares in Q1 2019, an estimated $2K.
Winslow Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 14 quarters.
Winslow Capital Management's Bristol-Myers Squibb position peaked at $684M in Q4 2015.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Winslow Capital Management's 13F filing for Q1 2019, filed 14 May 2019.